Universal Health Services shares surge 10.30% intraday as CEO contract extension and strong Q3 results drive analyst upgrades and higher price targets.

Universal Health Services (UHS) surged 10.3% intraday following strong third-quarter results that exceeded guidance and forecasts, prompting analyst upgrades and raised price targets. The company extended CEO Marc D. Miller’s contract through 2029, signaling stability, and reported performance that outpaced expectations in both Acute and Behavioral segments. Raymond James upgraded UHS to Outperform with a $270 price target, while Guggenheim and RBC Capital also raised their targets, citing solid core performance. Cantor Fitzgerald maintained a Neutral rating but affirmed a $250 target, suggesting achievable growth. These developments, combined with a $0.20 dividend announcement, reinforced investor confidence in UHS’s financial resilience and strategic direction.